Personalised versus non-individualised case-based CME: A randomised pilot study

J Eur CME. 2022 Nov 29;11(1):2153438. doi: 10.1080/21614083.2022.2153438. eCollection 2022.

Abstract

The PinPoint Case Platform (PPCP) offers independent online case-based CME. To align with personal learning needs, a functionality of needs assessments ("QuickScan") was developed, directing users to follow personalised case journeys. A randomised study was conducted, comparing its effectiveness, time efficiency and user experience with a format of non-individualised case-based learning. Forty-two residents in urology from five European countries were randomly assigned to follow non-individualised case-based learning (control group) or a needs assessment plus personalised case journeys on different topics in prostate cancer. After performing a pre- and post-assessment, both groups showed a similar increase in test scores (Mann-Whitney U = 247; p = .113), but the time needed for completing the learning exercise was significantly lower in the group with the personalised approach (median: 45 vs 90 minutes; Mann-Whitney U = 97.5; p = .0141). The quality of the two learning methods was similarly well received by both groups. In conclusion, learners who followed personalised case journeys learned similarly effective but more time efficient than non-individualised case-based learners. Future studies should determine if these findings can be extrapolated to board-certified physicians following CME activities.

Keywords: Continuing medical education; case-based learning; individualised learning; online CME; prostate cancer.

Grants and funding

The research and development of the individualised learning platform was funded by a grant received by the Flanders Agency for Innovation and Entrepreneurship (VLAIO) (grant agreement HBC.2019.2822).